Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 72,808 | 83,770 | 122,127 | 83,336 | 76,129 |
| Gross Profit | 72,808 | 83,770 | 122,127 | 83,336 | 76,129 |
| Operating Expenses | 4,823 | 3,960 | 3,776 | 5,779 | 104,556 |
| Operating Income | 67,985 | 79,810 | 118,351 | 77,557 | -28,427 |
| Interest Expense | 8,161 | 9,007 | 9,780 | 9,154 | 9,514 |
| Other Income | 131 | 130 | -609 | 175 | 1,164 |
| Pre-tax Income | 59,955 | 70,933 | 107,962 | 68,578 | -36,777 |
| Income Tax | 21,013 | 25,017 | 37,976 | 24,033 | -12,317 |
| Net Income Continuous | 38,942 | 45,916 | 69,986 | 44,545 | -24,460 |
| Net Income | $38,942 | $45,916 | $69,986 | $44,545 | $-24,460 |
| EPS Basic Total Ops | 0.28 | 0.33 | 0.50 | 0.32 | -0.23 |
| EPS Basic Continuous Ops | 0.28 | 0.33 | 0.50 | 0.32 | -0.23 |
| EPS Diluted Total Ops | 0.24 | 0.28 | 0.38 | 0.25 | -0.15 |
| EPS Diluted Continuous Ops | 0.24 | 0.27 | 0.38 | 0.23 | -0.15 |
| EBITDA(a) | $70,935 | $83,439 | $120,739 | $79,914 | $-26,139 |